Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.
By S. Winawer, A. Zauber, R. Fletcher, Jonathon S. Stillman, M. O'brien, B. Levin, Robert A. Smith, D. Lieberman, R. Burt, T. Levin and 9 more. Gastroenterology, 2006
793 citations recorded by the source corpus.
Subfields: Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/2721f5a75ecf069efda4f7543a1f05b163bd2367
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
In Pathology and Forensic Medicine
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Serrated Lesions of the Colorectum: Review and Recommendations From an Expert Panel (2012, background): “Post-polypectomy surveillance guidelines in the United States and Great Britain make recommendations for patients with adenomas based on observational studies that link baseline colonoscopy adenoma findings to the risk of an advanced adenoma at follow-up (140, 141).”
- Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. (2012, neutral): “The surveillance schema identified 2 major risk groups based on the likelihood of developing advanced neoplasia during surveillance: (1) low-risk adenomas (LRAs), defined as 1–2 tubular adenomas 10 mm, and (2) high-risk adenomas (HRAs), defined as adenoma with villous histology, highgrade dysplasia ”
- Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force (2008, methodology): “All individuals with an adenoma detected were followed with colonoscopy surveillance per the MultiSociety guidelines (27, 28).”